The ketogenic diet, a high-fat, low-carbohydrate, moderate-protein nutritional approach, has emerged as a promising treatment for anorexia nervosa, a severe eating disorder with a devastating impact on mental health and a high mortality rate. A recent study published in Communications Medicine by UC San Diego School of Medicine has demonstrated the feasibility and safety of this dietary intervention for patients with weight-normalized and mildly underweight anorexia nervosa. The findings are particularly significant as they offer a new avenue for treating a condition that has historically been challenging to manage effectively.
The study, led by Dr. Guido Frank, a seasoned expert in anorexia nervosa treatment, involved a 14-week ketogenic intervention under medical supervision. The results were impressive, with 82% of the 22 enrolled participants completing the study and showing remarkable improvements. Crucially, there was no significant weight loss, and eating disorder symptoms decreased significantly, with 72% of completers reaching the recovered range. Moreover, depression scores improved, with 72% of participants showing normal ranges.
This breakthrough is a testament to the potential of dietary interventions in treating anorexia nervosa. The study's co-author, Dr. Barbara Scolnick, shares a personal connection to the research, having witnessed the transformative power of ketogenic therapy through her niece's recovery from a 15-year struggle with anorexia. This personal journey underscores the importance of the study's findings.
The ketogenic diet's success in this study builds on previous research and provides a proof of concept for a treatment that has shown promise in other areas, such as epilepsy. By targeting neurometabolic dysfunction, a condition linked to anorexia nervosa, this approach may offer a way to regulate neural function and alleviate the psychological symptoms that often persist despite weight restoration.
However, the authors emphasize the need for specialized medical supervision and trained support when implementing ketogenic therapy. The study's positive outcomes highlight the potential for this dietary intervention to be a valuable addition to the treatment toolkit for anorexia nervosa, especially for those who have not responded to traditional therapies.
Looking ahead, the study's findings have sparked further research, including an extension targeting patients with both anorexia nervosa and bulimia nervosa. This expansion could significantly contribute to our understanding of the ketogenic diet's effectiveness in treating a broader range of eating disorders. The potential for ketogenic therapy to provide new hope for patients and their families is a compelling reason to continue exploring this innovative treatment approach.
